NSCLC Stage II Clinical Trials

12 clinical trials for NSCLC Stage II across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease — RECRUITING · PHASE2
• Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study — RECRUITING · NA
• Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC — RECRUITING · PHASE2
• Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial — NOT_YET_RECRUITING · PHASE2
• Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients — COMPLETED · PHASE2
• Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients — NOT_YET_RECRUITING · PHASE2
• A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China — COMPLETED
• Construction of a Prognostic and Prediction Model for Perioperative Immunotherapy in NSCLC: A Multi - Omics Perspective — NOT_YET_RECRUITING
• Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations — OTHER · PHASE2
• The Role of Microbiota on the Development of Lung Cancer — OTHER

Refine this search